THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $12,414,000 | -60.1% | 1,370,250 | -57.9% | 0.22% | -55.4% |
Q1 2022 | $31,115,000 | -52.9% | 3,254,713 | -45.5% | 0.50% | -40.5% |
Q4 2021 | $66,019,000 | +51.3% | 5,974,535 | +1.3% | 0.85% | +77.2% |
Q3 2021 | $43,624,000 | -34.2% | 5,895,159 | +29.2% | 0.48% | -28.5% |
Q2 2021 | $66,270,000 | -47.8% | 4,564,045 | -26.6% | 0.67% | -43.6% |
Q1 2021 | $126,932,000 | +14.9% | 6,219,110 | 0.0% | 1.19% | +22.8% |
Q4 2020 | $110,514,000 | +20.2% | 6,219,110 | 0.0% | 0.97% | -16.3% |
Q3 2020 | $91,950,000 | +71.5% | 6,219,110 | +143.5% | 1.16% | +53.1% |
Q2 2020 | $53,618,000 | +996.7% | 2,554,470 | +1107.5% | 0.76% | +820.7% |
Q1 2020 | $4,889,000 | – | 211,545 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $71,104,000 | 15.26% |
Newtyn Management, LLC | 2,495,860 | $25,308,000 | 5.56% |
Chescapmanager LLC | 1,160,503 | $11,768,000 | 2.74% |
Baupost Group | 13,419,226 | $136,071,000 | 2.35% |
Weiss Asset Management LP | 7,457,060 | $75,615,000 | 1.86% |
Park West Asset Management LLC | 1,919,354 | $19,462,000 | 1.38% |
Cannon Global Investment Management, LLC | 65,000 | $659,000 | 1.06% |
Oasis Management Co Ltd. | 296,960 | $3,011,000 | 0.51% |
Rubric Capital Management LP | 356,100 | $3,611,000 | 0.18% |
Sagefield Capital LP | 51,600 | $523,000 | 0.17% |